Guidelines on Active Pharmaceutical Ingredient (API)

NPRA Banner

Guidelines on Active Pharmaceutical Ingredient (API)

: Posted By Pharm Mee Ngoh; 16 Januari 2019; Jumlah paparan: 40144

Kadar pengguna: 5 / 5

Document Name	Download	Updated
DRGD - Appendix 11 : Regulatory Control Of Active Pharmaceutical Ingredients (APIs)		Jan-2024
Guidance Notes for API Information for Product Registration Application via QUEST (Version 6.1)		Jul-2022
Appendix IV: List of Atypical APIs		Jul-2023
List of Updates for Guidance Notes		Jul-2022
Guideline on Submission of Documentation for a Multisource (Generic) Finished Pharmaceutical Product (FPP):Quality Part.		Jan-2012
WHO Technical Report Series, No. 953, 2009 Annex 2: Stability testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products		Jan-2009

Rating:

( 4 Ratings )

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

Phone: +603-7883 5400

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

NPRA Product Status